Hedge Fund - Acuta Capital Partners
Arrowhead Pharmaceuticals Inc. (ARWR)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q3 (2023-09-30) | $0 | 0% | 0 | $30.63 |
| 2 | 2023 - Q2 (2023-06-30) | $980,650 | 0.66% | 27,500 | $34.48 |
| 3 | 2023 - Q1 (2023-03-31) | $0 | 0% | 0 | $31.45 |
| 4 | 2022 - Q4 (2022-12-31) | $1,664,136 | 1.02% | 41,029 | $33.13 |
| 5 | 2022 - Q3 (2022-09-30) | $2,892,000 | 1.24% | 87,500 | $40.36 |
| 6 | 2022 - Q2 (2022-06-30) | $2,180,000 | 1.21% | 61,926 | $37.62 |
| 7 | 2022 - Q1 (2022-03-31) | $3,794,000 | 1.77% | 82,500 | $49.51 |
| 8 | 2021 - Q4 (2021-12-31) | $6,995,000 | 2.94% | 105,500 | $68.71 |
| 9 | 2021 - Q3 (2021-09-30) | $7,585,000 | 2.67% | 121,500 | $64.75 |
| 10 | 2021 - Q2 (2021-06-30) | $8,945,000 | 3.57% | 108,000 | $74.45 |
| 11 | 2021 - Q1 (2021-03-31) | $7,161,000 | 2.58% | 108,000 | $77.59 |
| 12 | 2020 - Q4 (2020-12-31) | $10,665,000 | 2.9% | 139,000 | $63.95 |
| 13 | 2020 - Q3 (2020-09-30) | $4,371,000 | 1.18% | 101,500 | $43.15 |
| 14 | 2020 - Q2 (2020-06-30) | $2,591,000 | 0.74% | 60,000 | $35.29 |
| 15 | 2020 - Q1 (2020-03-31) | $3,156,000 | 1.52% | 109,700 | $40.33 |
| 16 | 2019 - Q4 (2019-12-31) | $28,068,000 | 6.95% | 442,500 | $49.62 |
| 17 | 2019 - Q2 (2019-06-30) | $12,680,000 | 4.5% | 478,500 | $21.95 |
| 18 | 2019 - Q1 (2019-03-31) | $3,074,000 | 1.46% | 167,500 | $16.50 |
| 19 | 2018 - Q4 (2018-12-31) | $0 | 0% | 0 | $13.67 |
| 20 | 2018 - Q3 (2018-09-30) | $14,857,000 | 5.29% | 775,000 | $16.41 |
| 21 | 2018 - Q2 (2018-06-30) | $14,012,000 | 2.49% | 1,030,330 | $9.35 |
| 22 | 2018 - Q1 (2018-03-31) | $12,706,000 | 2.07% | 1,762,206 | $6.16 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:10.0000 on 2011-11-17